TORONTO, July 31, 2024 /PRNewswire/ - Sun Life Financial Inc. (TSX: SLF) (NYSE: SLF) is pleased to announce the appointments of Patrick Cronin and Stacey Madge to the Sun Life Board of Directors, effective July 31, 2024. Mr. Cronin is a seasoned financial executive with a distinguished career spanning over 30 years in the banking and financial services industries across Canada, U.S. and international markets. Most recently, Mr. Cronin served as Special Advisor to the CEO for BMO Financial Group. Prior to th ...

文章核心观点 - 公司开发了首个用于治疗和功能性治愈慢性乙型肝炎病毒(HBV)感染的重组多克隆治疗药物GIGA-2339 [1][4][5] - GIGA-2339包含超过1,000种完全人源化的重组抗HBV抗体,可复制人体自然免疫反应 [2][7] - GIGA-2339是公司重组多克隆抗体药物平台的一部分,是Grifols公司创新战略和致力于为患者和医疗专业人员提供下一代抗体药物的一部分 [3][5] 行业概况 - 目前现有疗法和疫苗仍无法治愈HBV,全球仍有2.96亿人感染HBV,每年导致超过80万人死亡 [6] - 现有药物只能抑制病毒复制,但无法显著降低病毒蛋白水平,无法彻底治愈 [6][7] 公司情况 - 公司利用行业领先的单细胞技术,开发用于治疗免疫缺陷、传染病和难治性肿瘤的创新性抗体药物 [16] - 公司的重组多克隆抗体技术平台可以捕获和重现完整的免疫细胞谱系,从而创造出首创的重组多克隆抗体治疗药物 [9] - 公司的主要股东是Grifols公司,Grifols是一家全球性的医疗保健公司,致力于改善全球人民的健康和福祉 [10][14] - Grifols专注于治疗免疫学、肝病、重症监护、肺病、血液病、神经病和传染病等多个治疗领域 [11] - Grifols拥有全球最大的血浆捐赠中心网络,在北美、欧洲、非洲、中东和中国设有超过390个捐赠中心 [12] - Grifols还提供输血医学解决方案、生命科学研究用生物原料以及医院、药房和医疗专业人员所需的工具、信息和服务 [13]

MONTREAL and CHARLOTTE, N.C., July 31, 2024 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (NASDAQ:MIST) today announced that President and CEO, Joe Oliveto, will participate in the BTIG Virtual Biotechnology Conference, to take place from August 5-6, 2024. The presentation will be in the form of a Fireside Chat to take place on August 6th at 8 AM EDT. The webcast will be available to watch both live and as a replay for approximately 90 days following the presentation in the News & Events section of Mi ...

FORT MYERS, Fla., July 31, 2024 (GLOBE NEWSWIRE) -- American Oncology Network ("AON" or the "Company") (OTCQX:AONC), one of the fastest growing community-based oncology practices, announced today that the Company will release its second quarter 2024 financial results on Wednesday, August 14, 2024, prior to market open. The Company will host a conference call and live webcast with the investment community at 8:30 a.m. Eastern Time on the same day. To access the call through a conference line, dial 1-877-704- ...

LITTLE ROCK, Ark., July 31, 2024 (GLOBE NEWSWIRE) -- Inuvo, Inc. (NYSE:INUV), a leading provider of marketing technology, powered by its proprietary IntentKey® artificial intelligence (AI) that serves brands and agencies, has announced that it has secured a new $10 million asset-based credit facility to support its continued growth and operations. The credit facility, provided by SLR Digital Finance, provides Inuvo with enhanced liquidity and the financial flexibility to accelerate the adoption of its large ...

ISELIN, N.J., July 31, 2024 (GLOBE NEWSWIRE) -- Provident Bank, a leading New Jersey-based financial institution, is pleased to welcome Leonardo Ramos as Vice President, Community Reinvestment Act (CRA) Officer. Mr. Ramos is responsible for the execution of the bank's CRA program and commitments to the communities the bank serves, while overseeing the day-to-day operations of the bank's various assessment areas and carrying out executive leadership's directives to achieve specific CRA goals and objectives. ...

SAN DIEGO, July 31, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ:BNGO) today announced that it will host a conference call and live webcast on Wednesday, August 7, 2024, at 4:30 p.m. Eastern Time to report financial results for the second quarter 2024 and to highlight recent corporate progress. Conference Call & Webcast Details Date:Wednesday, August 7th, 2024Time:4:30 p.m. ETParticipant Link:Registration – Click HereWebcast Link:https://edge.media-server.com/mmc/p/jojadok2/ Participants may acce ...

LAWRENCEVILLE, N.J., July 31, 2024 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ:IMNN), a clinical-stage company in late-stage development with its DNA-mediated immunotherapy, today announced that it has entered into definitive securities purchase agreements for a registered direct offering of its common stock priced at-the-market under Nasdaq rules. In a concurrent private placement and also pursuant to the securities purchase agreements, the Company has agreed to issue to the investors unregistered warrants to ...

Fibromyalgia is a "diagnosable condition" in people suffering from Long COVID according to NASEM1 Diagnosing fibromyalgia in Long COVID patients is expected to expand the potential addressable market for Tonmya relative to pre-COVID-19 pandemic estimates2 Tonmya is a potential new first-line non-opioid analgesic under development for the management of fibromyalgia with Fast Track designation: NDA submission target is second half of 2024, with potential for FDA approval in 2025 CHATHAM, N.J., July 31, 2024 ( ...

Trading Symbols:    TSX/NYSE AMERICAN: SVM VANCOUVER, BC, July 31, 2024 /PRNewswire/ - Silvercorp Metals Inc. ("Silvercorp" or the "Company") (TSX: SVM) (NYSE American: SVM) is pleased to announce that it will proceed to close the acquisition of Adventus Mining Corporation ("Adventus") pursuant to the arrangement agreement (the "Arrangement Agreement") under which the Company agreed to acquire all of the issued and outstanding common shares of Adventus by way of a plan of arrangement (the "Transaction") as ...